VTR Ventas Inc.

Ventas Named to Dow Jones Sustainability World Index for First Time

Ventas, Inc., (NYSE: VTR) has enhanced its sustainability leadership position with the announcement of its first time inclusion on the 2019 Dow Jones Sustainability™ World Index, and retaining its place on the Dow Jones Sustainability North America Index. In addition, Ventas has maintained its #1 position among the four listed healthcare real estate participants in the GRESB real estate ESG (environment, social, governance) assessment for the third consecutive year.

“Our long term commitment to ESG principles animates our actions, decisions and processes and drives success for shareholders, partners and employees,” said Debra A. Cafaro, Chairman and Chief Executive Officer. “We are honored that our ESG leadership has been acknowledged once again in these two prestigious global rankings.”

About DJSI: Celebrating its 20th anniversary in 2019, DJSI was launched as the first global sustainability benchmark to track the largest and leading sustainability-driven publicly listed companies in terms of economic, environmental and social criteria. Approximately 4,500 companies are asked to participate in the Corporate Sustainability Assessment. Only companies that rank within the top 10% of their industries are included in the DJSI World Index.

About GRESB: GRESB is the ESG benchmark for real assets. The 2019 GRESB Real Estate benchmark covers more than 1,000 property companies, real estate investment trusts (REITs), funds, and developers.

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of senior housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to “Ventas” or the “Company” mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at and .

EN
17/09/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ventas Inc.

Ventas Inc: 2 directors

Two Directors at Ventas Inc sold after exercising options/sold 40,252 shares at between 77.253USD and 77.260USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the comp...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch